Transplantation in the treatment of diabetes

Czech version

Authors: F. Saudek
Authors‘ workplace: Klinika diabetologie IKEM Praha, přednostka prof. MUDr. Terezie Pelikánová, DrSc.
Published in: Vnitř Lék 2007; 53(7-8): 859-864
Category:

Overview

Diabetes mellitus continues to be the most common cause of chronic kidney failure, blindness acquired in adulthood, non-traumatic amputations and severe forms of neuropathy. Therefore it is necessary to look for new forms of therapy capable of achieving long-term normalisation of blood sugar levels. The only standard method so far is pancreas transplantation. Most often, it is performed in combination with kidney transplantation and only exceptionally as an isolated procedure. A new and considerably less invasive option is transplantation of isolated Langerhans islets. While the number of pancreas transplantations in IKEM has exceeded 300, the program of islet transplantation is in its formative phase, with 10 clinical surgeries having been performed since May 2007. However, the number of suitable patients who could benefit from this method of treatment largely exceeds the availability of organs suitable for transplantation. Therefore, new possibilities of acquiring insulin producing cell lines are searched for, both from animal tissue and, primarily, from embryonic or adult stem cells. Also the possibility of in vivo regeneration of endogenous or transplanted β cells of the pancreas has now became an object of study. Combined transplantation of the kidney and pancreas is still the best available method in the treatment of uremic type 1 diabetes patients and its long-term results have shown to be very good, even though their further improvement has been but of a lesser degree. Isolated transplantation of the pancreas is still reserved for a limited group of patients with very labile diabetes. The transplantation of isolated Langerhans isletes is an alternative option which is far safer for the patient, but the long-term results of which still leave much to be desired. The method currently used in the Institute of Clinical and Experimental Medicine (IKEM) is organ transplantation of the pancreas while a program of transplantation of isolated islets has been launched, and also studied are the possibilities of insulin producing cell lines propagation.

Key words:
diabetes mellitus – transplantation – pancreas – Langerhans islets

Sources

1. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 10: 1676-1685.

2. Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ 2006; 333: 475-480.

3. Saudek F, Adamec M, Ekberg H et al. First experience with combined pancreatic-renal transplantation with extraperitoneal placement of the whole pancreatic graft. Transplant Proc 1995; 27: 3080-3081.

4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.

5. Landgraf R. Impact of pancreas transplantation on diabetic secondary complications and quality of life. Diabetologia 1996; 39: 1415-1424.

6. Hirata M, Cho YW, Cecka JM et al. Patient death after renal transplantation - an analysis of its role in graft outcome. Transplantation 1996; 61: 1479-1483.

7. Saudek F, Adamec M, Bouček P et al. Tři sta transplantací pankreatu v Institutu klinické a experimentální medicíny v Praze. Prakt Lék 2007; 87: 76-81.

8. Mindlová M, Saudek F. Autonomní selhání způsobené recidivujícími hypoglykémiemi, jeho klinické hodnocení a terapie. Prakt Lék 2007; 87: 52-57.

9. Sutherland DER, Najarian JS et al. Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus. Transplantation 1997; 64: 1572-1577.

10. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.

11. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-2069.

12. Shapiro AM, Ricordi C, Hering BJ et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006; 355: 1318-1330.

13. Ibrahim Z, Busch J, Awwad M et al. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 2006; 13: 488-499.

14. Koblas T, Harman SM, Saudek F. The application of umbilical cord blood cells in the treatment of diabetes mellitus. Rev Diabet Stud 2005; 2: 228-234.

15. Koblas T , Zacharovová K, Berková Z et al. Isolation and characterisation of human Cxcr4 positive pancreatic cells. Folia Biologica 2007; 53: 13-22.

16. Ouziel-Yahalom L, Zalzman M, Anker-Kitai L et al. Expansion and redifferentiation of adult human pancreatic islet cells. Biochem Biophys Res Commun 2006; 341: 291-298.